100 days with John Crowley: Behind BIO’s new structure & vision
Jun 25, 2024 · Chutes & Ladders—BIO lands rare disease advocate John Crowley as CEO. The redesign is tooled to give leaders more resources, Crowley said, though the restructure led to the departure of 30...
BIO CEO John Crowley interview: China, vaccines, and Trump - STAT
Jul 18, 2024 · W ASHINGTON — BIO’s new CEO John Crowley is making changes. He’s pivoting the biotechnology industry’s largest trade association away from a focus on controversial social issues.
He Designed Drugs to Save His Children. Now He’s Working to …
Dec 5, 2023 · Nearly a quarter-century after plunging into biotech to find drugs to save Megan and her younger brother, Patrick, from a rare and deadly genetic disease, Crowley feared the battle had suddenly...
BIO selects John Crowley as new CEO - STAT
Dec 5, 2023 · W ASHINGTON — The Biotechnology Innovation Organization has chosen longtime biotech executive and rare disease advocate John Crowley as its new CEO, the organization announced Tuesday....
John Crowley (businessman) - Wikipedia
John Francis Crowley (born April 7, 1967) is the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy organization. [1] He served as the chairman and CEO of Amicus Therapeutics.
Would BIO support a biosecurity bill targeting drug developers?
Jun 7, 2024 · The Biotechnology Innovation Organization, under the new leadership of CEO John Crowley, recently backed the BIOSECURE Act. The bill has so far only targeted certain Chinese biopharma service...
Meet John Crowley: Biotech Visionary, Devoted Father, and New …
Jun 17, 2024 · As the newly appointed President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology advocacy group, Crowley brings a unique blend of personal passion and professional expertise to his role.
Industry Leader and Globally Recognized Patient Advocate John F …
Dec 5, 2023 · The Biotechnology Innovation Organization (BIO) is proud to announce that industry leader and military veteran John F. Crowley will be its new President and CEO, effective March 4.
Why biomanufacturing is critical for America's national security - Bio.News
Mar 20, 2024 · Bolstering America’s biomanufacturing capabilities is critical to national security and a key priority of BIO's new President & CEO, John F. Crowley.
BIO names longtime Amicus head John Crowley as new CEO
Dec 5, 2023 · The Biotech Innovation Organization on Tuesday named Amicus Therapeutics co-founder and longtime leader John Crowley as its new CEO, taking over a spot interim chief Rachel King has held for the past 14 months.